Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Ralph R. Minter"'
Autor:
Christina Schindler, Andie Collinson, Carl Matthews, Amy Pointon, Lesley Jenkinson, Ralph R Minter, Tristan J Vaughan, Natalie J Tigue
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0214545 (2019)
Doxorubicin is a chemotherapeutic agent that is commonly used to treat a broad range of cancers. However, significant cardiotoxicity, associated with prolonged exposure to doxorubicin, limits its continued therapeutic use. One strategy to prevent the
Externí odkaz:
https://doaj.org/article/d2a3717382b14d8298b565839ea17c6b
Autor:
Julie Douthwaite, Jacques Moisan, Cyril Privezentzev, Blagoje Soskic, Shereen Sabbah, Suzanne Cohen, Andie Collinson, Elizabeth England, Catherine Huntington, Ben Kemp, Li Zhuang, Suzanne Hudak, D. Gareth Rees, Debbie Goldberg, Chris Barton, Linda Chang, Inna Vainshtein, Meina Liang, Laurie Iciek, Philip Ambery, Mark Peakman, Tristan J. Vaughan, Tim I. M. Tree, David M. Sansom, Michael A. Bowen, Ralph R. Minter, Lutz Jermutus
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 199(5)
Autor:
John D. Horton, Rebecca Stewart, Ralph R. Minter, Pamela Ritchie, Yuko Ohta, Trudy L. Horton, Martin F. Flajnik, Martin D. Watson, Terry Gibbons
Publikováno v:
Developmental & Comparative Immunology. 29:723-732
cDNAs for Xenopus β2-microglobulin (β2m), the obligatory light chain of most vertebrate Major Histocompatibility Complex (MHC) class I molecules, were isolated and ESTs were identified. Alignment of the deduced amino acid sequence to other species'
Autor:
Trudy L. Horton, Ralph R. Minter, John D. Horton, Martin D. Watson, Pamela Ritchie, Rebecca Stewart
Publikováno v:
European Journal of Immunology. 30:604-613
Early-thymectomized (Tx) Xenopus frogs, which are permanently deficient in T cells, are used as a model sytem for the characterization of novel monoclonal antibodies (mAb) which identify candidate NK cells at the amphibian level of evolution. Hybrido
Autor:
Rebecca, Stewart, Yuko, Ohta, Ralph R, Minter, Terry, Gibbons, Trudy L, Horton, Pamela, Ritchie, John D, Horton, Martin F, Flajnik, Martin D, Watson
Publikováno v:
Developmental and comparative immunology. 29(8)
cDNAs for Xenopus beta2-microglobulin (beta2m), the obligatory light chain of most vertebrate Major Histocompatibility Complex (MHC) class I molecules, were isolated and ESTs were identified. Alignment of the deduced amino acid sequence to other spec
Autor:
Ian Gravawr, Martin D. Watson, Lanier Ganluna, Ralph R. Minter, Pamela Ritchie, Max Caopet, Trudy L. Horton, Robin C. Dzialo, John D. Horton
Publikováno v:
Immunological reviews. 166
The Xenopus early-thymectomy model system is used to investigate the extent to which the thymus controls T-cell development and to probe the evolution of natural killer (NK) cells. Loss of T-cell function following thymectomy, together with the pauci
Autor:
I. Gravenor, Ralph R. Minter, Pamela Ritchie, Martin D. Watson, Trudy L. Horton, John D. Horton
Publikováno v:
Developmental & Comparative Immunology. 21:237
Autor:
Kevin P. Baker, Bryan M. Edwards, Sarah H. Main, Gil H. Choi, Ruth E. Wager, Wendy G. Halpern, Patrick B. Lappin, Todd Riccobene, Donara Abramian, Les Sekut, Bonnie Sturm, Carol Poortman, Ralph R. Minter, Claire L. Dobson, Elizabeth Williams, Sara Carmen, Rodger Smith, Viktor Roschke, David M. Hilbert, Tristan J. Vaughan
Publikováno v:
Arthritis & Rheumatism; Nov2003, Vol. 48 Issue 11, p3253-3265, 13p
Autor:
Berry SK; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.; Antibody Discovery and Protein Engineering, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Rust S; Antibody Discovery and Protein Engineering, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Irving L; Antibody Discovery and Protein Engineering, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Bartholdson Scott J; Cambridge Institute for Therapeutic Immunology & Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Weinert LA; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom., Dougan G; Cambridge Institute for Therapeutic Immunology & Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Christie G; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom., Warrener P; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Minter R; Antibody Discovery and Protein Engineering, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Grant AJ; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Publikováno v:
Microbiology spectrum [Microbiol Spectr] 2024 Aug 06; Vol. 12 (8), pp. e0040024. Date of Electronic Publication: 2024 Jun 28.
Autor:
Sammut SJ; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. stephen-john.sammut@icr.ac.uk.; The Royal Marsden Hospital NHS Foundation Trust, London, UK. stephen-john.sammut@icr.ac.uk., Galson JD; Alchemab Therapeutics, Whittlesford, UK., Minter R; Alchemab Therapeutics, Whittlesford, UK., Sun B; Wellcome Centre for Human Genetics, Oxford, UK.; Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK., Chin SF; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., De Mattos-Arruda L; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain., Finch DK; Alchemab Therapeutics, Whittlesford, UK., Schätzle S; Alchemab Therapeutics, Whittlesford, UK., Dias J; Alchemab Therapeutics, Whittlesford, UK., Rueda OM; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Seoane J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Institució Catalana de Recerca i Estudis Avançats (ICREA), Universitat Autònoma de Barcelona (UAB), CIBERONC, Barcelona, Spain., Osbourn J; Alchemab Therapeutics, Whittlesford, UK., Caldas C; School of Clinical Medicine, University of Cambridge, Cambridge, UK. cc234@cam.ac.uk., Bashford-Rogers RJM; Wellcome Centre for Human Genetics, Oxford, UK. rachael.bashford-rogers@bioch.ox.ac.uk.; Department of Biochemistry, University of Oxford, Oxford, UK. rachael.bashford-rogers@bioch.ox.ac.uk.; Oxford Cancer Centre, Oxford, UK. rachael.bashford-rogers@bioch.ox.ac.uk.
Publikováno v:
Nature immunology [Nat Immunol] 2024 May; Vol. 25 (5), pp. 916-924. Date of Electronic Publication: 2024 May 02.